• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非典型 pANCA 作为不确定结肠炎的标志物,可预测溃疡性结肠炎和克罗恩病。

Atypical pANCA as a marker of indeterminate colitis for the prediction of ulcerative colitis and Crohn's disease.

机构信息

Department of Gastroenterology, Turkiye Yuksek Ihtisas Training and Research Hospital, Kızılay sok. No. 2, 06100, Sıhhıye, Ankara, Turkey.

出版信息

Wien Klin Wochenschr. 2013 May;125(9-10):279-82. doi: 10.1007/s00508-013-0363-x. Epub 2013 Apr 26.

DOI:10.1007/s00508-013-0363-x
PMID:23619641
Abstract

AIM

The aim of this study was to demonstrate that the presence of atypical perinuclear antineutrophil cytoplasmic antibodies (pANCA) in indeterminate colitis (IC) patients and the potential role of pANCA for predicting the patients either with ulcerative colitis (UC) or Crohn's disease (CD) for UC and CD.

MATERIAL AND METHODS

Outpatients and inpatients from the hospital were retrospectively enrolled between April 2008 and December 2010. A total of 25 IC patients enrolled in the present study. Subsequently, 25 randomly selected serum samples were tested for pANCA in our laboratory. Determination of pANCA was performed by enzyme linked immunosorbent assay.

RESULTS

Minimum follow-up was 12 months. The mean duration of disease was 20.52 months. The diagnosis was changed to UC in 13, to CD in 5 patients. The remaining 7 patients are still classified with IC, with mean disease duration of 21.29 months. Duration of disease differs statistically when comparing pANCA positive versus pANCA negative. A positive correlation was found between IC and disease location in our study.

CONCLUSION

Patients with an initial diagnosis of IC who have positive serology are given a definitive diagnosis of UC or CD, respectively, more often than patients with negative serology.

摘要

目的

本研究旨在证明不典型核周型抗中性粒细胞胞浆抗体(pANCA)在不确定结肠炎(IC)患者中的存在,以及 pANCA 预测患者为溃疡性结肠炎(UC)或克罗恩病(CD)的潜在作用。

材料和方法

2008 年 4 月至 2010 年 12 月期间,我们回顾性地招募了来自医院的门诊和住院患者。本研究共纳入 25 例 IC 患者。随后,在我们的实验室中检测了 25 例随机选择的血清样本中的 pANCA。通过酶联免疫吸附试验测定 pANCA。

结果

最小随访时间为 12 个月。疾病的平均持续时间为 20.52 个月。13 例诊断为 UC,5 例诊断为 CD。其余 7 例仍归类为 IC,平均疾病持续时间为 21.29 个月。比较 pANCA 阳性与 pANCA 阴性时,疾病持续时间存在统计学差异。在我们的研究中,发现 IC 与疾病部位之间存在正相关。

结论

在初始诊断为 IC 的患者中,阳性血清学患者比阴性血清学患者更常被明确诊断为 UC 或 CD。

相似文献

1
Atypical pANCA as a marker of indeterminate colitis for the prediction of ulcerative colitis and Crohn's disease.非典型 pANCA 作为不确定结肠炎的标志物,可预测溃疡性结肠炎和克罗恩病。
Wien Klin Wochenschr. 2013 May;125(9-10):279-82. doi: 10.1007/s00508-013-0363-x. Epub 2013 Apr 26.
2
[Anti-neutrophil cytoplasmic antibodies in the diagnosis of ulcerative colitis and Crohn's disease].[抗中性粒细胞胞浆抗体在溃疡性结肠炎和克罗恩病诊断中的应用]
Med Clin (Barc). 2004 Feb 7;122(4):134-5. doi: 10.1016/s0025-7753(04)74171-8.
3
Characteristics of inflammatory bowel disease serology in patients with indeterminate colitis.不确定性结肠炎患者炎症性肠病血清学特征
J Clin Gastroenterol. 2014 Apr;48(4):351-5. doi: 10.1097/MCG.0000000000000083.
4
The value of serologic markers in indeterminate colitis: a prospective follow-up study.血清学标志物在不确定性结肠炎中的价值:一项前瞻性随访研究。
Gastroenterology. 2002 May;122(5):1242-7. doi: 10.1053/gast.2002.32980.
5
pANCA and ASCA in Children with IBD-Unclassified, Crohn's Colitis, and Ulcerative Colitis-A Longitudinal Report from the IBD Porto Group of ESPGHAN.IBD未分类、克罗恩结肠炎和溃疡性结肠炎患儿中的核周型抗中性粒细胞胞浆抗体和抗酿酒酵母抗体——欧洲儿科胃肠病、肝病和营养学会IBD波尔图小组的纵向报告
Inflamm Bowel Dis. 2016 Aug;22(8):1908-14. doi: 10.1097/MIB.0000000000000784.
6
pANCA and ASCA in the diagnosis of different subtypes of inflammatory bowel disease.抗中性粒细胞胞浆抗体(pANCA)和抗酿酒酵母抗体(ASCA)在炎症性肠病不同亚型诊断中的应用
Hepatogastroenterology. 2007 Jul-Aug;54(77):1443-8.
7
Evaluation of serological markers to differentiate between ulcerative colitis and Crohn's disease: pANCA, ASCA and agglutinating antibodies to anaerobic coccoid rods.评估用于鉴别溃疡性结肠炎和克罗恩病的血清学标志物:抗中性粒细胞胞浆抗体(pANCA)、抗酿酒酵母抗体(ASCA)以及抗厌氧球杆状菌凝集抗体。
Eur J Gastroenterol Hepatol. 2002 Sep;14(9):1013-8. doi: 10.1097/00042737-200209000-00013.
8
Anti-Saccharomyces cerevisiae antibodies are associated with the development of postoperative fistulas following ileal pouch-anal anastomosis.抗酿酒酵母抗体与回肠贮袋肛管吻合术后瘘管的发生有关。
J Gastrointest Surg. 2006 Jul-Aug;10(7):1060-4. doi: 10.1016/j.gassur.2006.02.004.
9
[Diagnostic role of anti-saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease].[抗酿酒酵母抗体和抗中性粒细胞胞浆自身抗体在炎症性肠病中的诊断作用]
Zhonghua Nei Ke Za Zhi. 2005 Jun;44(6):428-30.
10
Prevalence and significance of perinuclear anti-neutrophil antibodies (pANCA) in Romanian patients with Crohn's disease and ulcerative colitis.罗马尼亚克罗恩病和溃疡性结肠炎患者中核周抗中性粒细胞抗体(pANCA)的患病率及意义
Rom J Gastroenterol. 2005 Dec;14(4):357-60.

引用本文的文献

1
Biological markers of disease activity in inflammatory bowel diseases.炎症性肠病疾病活动的生物标志物
Prz Gastroenterol. 2023;18(2):141-147. doi: 10.5114/pg.2023.129412. Epub 2023 Jul 27.

本文引用的文献

1
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis.欧洲关于溃疡性结肠炎诊断与管理的第二项循证共识 第1部分:定义与诊断
J Crohns Colitis. 2012 Dec;6(10):965-90. doi: 10.1016/j.crohns.2012.09.003. Epub 2012 Oct 3.
2
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management.第二届欧洲克罗恩病诊断与管理循证共识:当前管理
J Crohns Colitis. 2010 Feb;4(1):28-62. doi: 10.1016/j.crohns.2009.12.002. Epub 2010 Jan 15.
3
Indeterminate colitis.
不确定性结肠炎。
Tech Coloproctol. 2007 Jun;11(2):91-6. doi: 10.1007/s10151-007-0337-y. Epub 2007 May 25.
4
Do serological markers and cytokines determine the indeterminate?血清学标志物和细胞因子能确定不确定因素吗?
J Clin Gastroenterol. 2004 May-Jun;38(5 Suppl 1):S51-6. doi: 10.1097/01.mcg.0000124026.92823.fc.
5
Diagnosing colitis: a prospective study on essential parameters for reaching a diagnosis.
Endoscopy. 2003 Dec;35(12):1004-8. doi: 10.1055/s-2003-44593.
6
The value of serologic markers in indeterminate colitis: a prospective follow-up study.血清学标志物在不确定性结肠炎中的价值:一项前瞻性随访研究。
Gastroenterology. 2002 May;122(5):1242-7. doi: 10.1053/gast.2002.32980.
7
Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease.抗酿酒酵母抗体和抗中性粒细胞胞浆自身抗体在炎症性肠病中的诊断价值
Am J Gastroenterol. 2001 Mar;96(3):730-4. doi: 10.1111/j.1572-0241.2001.03613.x.
8
Frequency and clinical evolution of indeterminate colitis: a retrospective multi-centre study in northern Italy. GSMII (Gruppo di Studio per le Malattie Infiammatorie Intestinali).不确定性结肠炎的发病率及临床演变:意大利北部一项回顾性多中心研究。GSMII(肠道炎症性疾病研究组)
Eur J Gastroenterol Hepatol. 1999 Aug;11(8):909-13.
9
Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role.抗酿酒酵母甘露聚糖抗体与抗中性粒细胞胞浆自身抗体联合检测在炎症性肠病中的患病率及诊断作用
Gut. 1998 Jun;42(6):788-91. doi: 10.1136/gut.42.6.788.
10
Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroup.克罗恩病患者的核周抗中性粒细胞胞浆抗体可界定一个临床亚组。
Gastroenterology. 1996 Jun;110(6):1810-9. doi: 10.1053/gast.1996.v110.pm8964407.